PDCD1 and neoplasm: Treg cell infiltration was found to be dramatically reduced after in vivo administration of a mouse glioma model with an miR-138 mimic, which suppressed the expression of CTLA-4, PD-1, and Foxp3 in tumor-infiltrating CD4+T cells (79).